Quantum-Si Inc Ordinary Shares - Class A QSI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Quantum-Si Achieves Historic Milestone in Protein Sequencing with Single-Molecule Detection of All 20 Amino Acids on Proteus™
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quantum-Si Reports Third Quarter 2026 Financial Results and Provides Business Update
Quantum-Si to Provide a Business Update and Report Third Quarter 2026 Financial Results on November 5, 2026
Quantum-Si Regains Compliance with Nasdaq Minimum Bid Price Requirement
Quantum-Si Demonstrates Detection of 19 Amino Acids in Proteus™ Development Program
Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum® Pro
Quantum-Si Announces Detection of 18 Amino Acids Using a Developmental Sequencing Kit on Proteus™
Trading Information
- Previous Close Price
- $1.07
- Day Range
- $0.89–1.04
- 52-Week Range
- $0.69–1.81
- Bid/Ask
- $0.93 / $0.93
- Shares Outstanding
- 219.74M
- Market Cap
- $199.75M
- Volume/Avg
- 8M / 7M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 156.13
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 145
- Website
- https://www.quantum-si.com
Valuation
Metric | QSI |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.25 |
Price/Sales | 156.13 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | QSI |
|---|---|
Quick Ratio | 8.89 |
Current Ratio | 9.64 |
Interest Coverage | — |
Quick Ratio
QSI
Profitability
Metric | QSI |
|---|---|
Return on Assets (Normalized) | −33.71% |
Return on Equity (Normalized) | −36.72% |
Return on Invested Capital (Normalized) | −39.61% |
Return on Assets
QSI
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|?MmTD% | LOCK|x%?b | $178B | |||
| Medtronic PLC MDT | LOCK|C@$pK@v | LOCK|r<Hn! | $128B | |||
| Stryker Corp SYK | LOCK|%xHvwn$@ | LOCK|G! | $118B | |||
| Boston Scientific Corp BSX | LOCK|$?<?!Xy | LOCK|#fH> | $61B | |||
| Edwards Lifesciences Corp EW | LOCK|rRhh><bC | LOCK|>G!b$ | $59B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|$y!^@k! | LOCK|!sx | $36B | |||
| DexCom Inc DXCM | LOCK|mcwT#tP | LOCK|N@PP% | $30B | |||
| Koninklijke Philips NV ADR PHG | LOCK|J^@ | LOCK|$B< | $28B | |||
| Steris PLC STE | LOCK|>h?XMR | LOCK|$cLj! | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|wfL@#F^ | LOCK|^Ts | $19B |